Literature DB >> 25435399

cCMP and cUMP: emerging second messengers.

Roland Seifert1.   

Abstract

The cyclic purine nucleotides cAMP and cGMP are established second messengers. By contrast, the existence of the cyclic pyrimidine nucleotides cytidine 3',5'-cyclic monophosphate (cCMP) and uridine 3',5'-cyclic monophosphate (cUMP) has been controversial for decades. The recent development of highly sensitive mass spectrometry (MS) methods allowed precise quantitation and unequivocal identification of cCMP and cUMP in cells. Importantly, cCMP and cUMP generators, effectors, cleaving enzymes, and transporters have now been identified. Here, I discuss evidence in support of cCMP and cUMP as bona fide second messengers, the emerging therapeutic implications of cCMP and cUMP signaling, and important unresolved questions for this field.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  bacterial toxins; cCMP; cUMP; nucleotidyl cyclases; phosphodiesterases; protein kinases

Mesh:

Substances:

Year:  2014        PMID: 25435399     DOI: 10.1016/j.tibs.2014.10.008

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  12 in total

1.  cCMP and cUMP occur in vivo.

Authors:  Heike Bähre; Christina Hartwig; Antje Munder; Sabine Wolter; Tane Stelzer; Bastian Schirmer; Ulrike Beckert; Dara W Frank; Burkhard Tümmler; Volkhard Kaever; Roland Seifert
Journal:  Biochem Biophys Res Commun       Date:  2015-03-31       Impact factor: 3.575

2.  cUMP hydrolysis by PDE3A.

Authors:  Stefan Berrisch; Jessica Ostermeyer; Volkhard Kaever; Solveig Kälble; Denise Hilfiker-Kleiner; Roland Seifert; Erich H Schneider
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

3.  Naunyn-Schmiedeberg's Archives of Pharmacology under new editorship: change and continuity.

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-24       Impact factor: 3.000

4.  Bacterial Nucleotidyl Cyclase Inhibits the Host Innate Immune Response by Suppressing TAK1 Activation.

Authors:  Chenxi He; Yilong Zhou; Feng Liu; Haipeng Liu; Hao Tan; Shouguang Jin; Weihui Wu; Baoxue Ge
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

Review 5.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

6.  Cyclic CMP and cyclic UMP mediate bacterial immunity against phages.

Authors:  Nitzan Tal; Benjamin R Morehouse; Adi Millman; Avigail Stokar-Avihail; Carmel Avraham; Taya Fedorenko; Erez Yirmiya; Ehud Herbst; Alexander Brandis; Tevie Mehlman; Yaara Oppenheimer-Shaanan; Alexander F A Keszei; Sichen Shao; Gil Amitai; Philip J Kranzusch; Rotem Sorek
Journal:  Cell       Date:  2021-10-12       Impact factor: 66.850

7.  Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.

Authors:  K A Morrow; R Seifert; V Kaever; A L Britain; S L Sayner; C D Ochoa; E A Cioffi; D W Frank; T C Rich; T Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

Review 8.  The lost language of the RNA World.

Authors:  James W Nelson; Ronald R Breaker
Journal:  Sci Signal       Date:  2017-06-13       Impact factor: 8.192

Review 9.  Modulation of Compartmentalised Cyclic Nucleotide Signalling via Local Inhibition of Phosphodiesterase Activity.

Authors:  Marcella Brescia; Manuela Zaccolo
Journal:  Int J Mol Sci       Date:  2016-10-02       Impact factor: 5.923

Review 10.  Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes.

Authors:  Nikoleta Pavlaki; Viacheslav O Nikolaev
Journal:  J Cardiovasc Dev Dis       Date:  2018-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.